Quick Answer
RetinalGenix Technologies Inc. reported Cash And Cash Equivalents At Carrying Value of $38.00 for the year ending 2022.
- RetinalGenix Technologies Inc. showed a decrease of -99.2% in Cash And Cash Equivalents At Carrying Value from 2021 to 2022.
- This data is from RetinalGenix Technologies Inc.'s annual report (Form 10-K), filed with the SEC on April 1, 2024.
- XBRL data for this metric is available from 2020 to 2022 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2019: $54.4 thousand | Q3 2020: $30.1 thousand | Q3 2021: $36.6 thousand | Q2 2022: $27.00 | Q3 2022: $3.6 thousand | Q1 2023: $7.5 thousand | Q2 2023: $1.9 thousand | Q3 2023: $44.00.
- Over the full 3 years of available data (2020 to 2022), RetinalGenix Technologies Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 98.3%.
- Historical annual values: Fiscal year 2022: $38.00 | Fiscal year 2021: $4.9 thousand | Fiscal year 2020: $2.2 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: